Skip to main content
Charles Hong, MD, Cardiology, East Lansing, MI

CharlesChansikHongMDPHD, FAHA

Cardiology • East Lansing, MI

Non-Invasive Cardiology, Cardiovascular Disease Genetics

Chair of Medicine, Michigan State University College of Human Medicine

Join to view full profile

Dr. Hong is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hong's full profile

Already have an account?

  • Office

    B425 Clinical Center
    788 Service Road
    East Lansing, MI 48824
    Phone+1 517-353-5100
    Fax+1 517-432-9471
  • Is this information wrong?

Summary

  • I am a physician-scientist and an entrepreneur. I am the incoming Chair of Medicine at Michigan State University and Director of Clinician Scientist Development at Henry Ford Health.

    My research functions at the intersection of chemical biology, developmental biology, stem cell biology, and cardiovascular biology. Among my scientific contributions is the discovery of the role of Phosphoinositide 3-kinases (PI3K) in vein specification during vasculogenesis, which foreshadowed aberrant PI3K activation as a common cause of clinical venous malformations. I also discovered the first small molecule inhibitor of bone morphogenetic protein (BMP) signaling, which directly catalyzed the development of a clinical stage therapeutic program for devastating human diseases. My ongoing investigations studies include unraveling the essential role of centrosome reorganization in postnatal heart maturation, and developing novel therapies targeting of a key pro-oncogenic signaling pathway activated downstream of Warburg Effect. I edited one of the first books focused on chemical biology of stem cell and regenerative medicine, and a book covering the latest methods in chemical biology. I am the Specialty Chief Editor of Frontiers in Drug Discovery. I am an elected member of the American Society for Clinical Investigation (ASCI) and a Fellow of the American Association for the Advancement of Science (AAAS). I am a passionate advocate for medical education, having served as the Chair of the Scientific Committee and on the Board of Directors of the Sarnoff Foundation for Cardiovascular Research. Prior to MSU, I was the Melvin Sharoky, MD, Professor of Medicine, Co-Chief of Cardiovascular Medicine, and Director of Cardiology Research at the University of Maryland School of Medicine. Prior to that, I was on faculty at Vanderbilt University and Harvard Medical School. My clinical expertise is in cardiovascular genetics and inherited cardiomyopathies.

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Cardiovascular Disease, 2001 - 2004
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Internal Medicine, 1998 - 2001
  • Yale School of Medicine
    Yale School of MedicineClass of 1998

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2023 - 2026
  • MD State Medical License
    MD State Medical License 2018 - 2024
  • TN State Medical License
    TN State Medical License 2006 - 2019
  • MA State Medical License
    MA State Medical License 2001 - 2008
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Fellow, AAAS American Association for the Advancement of Science, 2020
  • Fellow, American Heart Association AHA, 2013
  • American Society for Clinical Investigation Inductee ASCI, 2013
  • Join now to see all

Publications & Presentations

PubMed

Other

Authored Content

  • Heart Failure, Hope, and the Hurdles Ahead for XenotransplantationFebruary 2022

Press Mentions

  • Research Could Lead to Potential New Ways to Predict and Prevent Stroke in Young Adults
    Research Could Lead to Potential New Ways to Predict and Prevent Stroke in Young AdultsSeptember 1st, 2022
  • Your Blood Type Can Predict Your Stroke Risk Before Age 60
    Your Blood Type Can Predict Your Stroke Risk Before Age 60August 31st, 2022
  • Improving West Baltimore Cardiovascular Health
    Improving West Baltimore Cardiovascular HealthAugust 4th, 2022
  • Join now to see all

Professional Memberships

Other Languages

  • Korean

External Links

Dr. Charles Hong, Dr. Charles Hong, MD, Dr. C Hong, Dr. Charles Chansik Hong